Literature DB >> 28614209

Newly Described Entities in Salivary Gland Pathology.

Alena Skálová1, Douglas R Gnepp, James S Lewis, Jennifer L Hunt, Justin A Bishop, Henrik Hellquist, Alessandra Rinaldo, Vincent Vander Poorten, Alfio Ferlito.   

Abstract

Salivary glands may give rise to a wide spectrum of different tumors. This review concentrates on 4 salivary gland tumors that have been accepted in the recent literature as new neoplastic entities: mammary analog secretory carcinoma, cribriform adenocarcinoma of minor salivary glands (CASG), sclerosing polycystic adenosis/adenoma (SPA), and the mucinous/secretory variant of myoepithelioma. Mammary analog secretory carcinoma is a distinctive low-grade malignant salivary cancer that harbors a characteristic chromosomal translocation, t(12;15) (p13;q25), resulting in an ETV6-NTRK3 fusion. Cribriform adenocarcinoma (CASG) is a distinct tumor entity that differs from polymorphous low-grade adenocarcinoma by location (ie, most often arising on the tongue), by prominent nuclear clearing, differing alterations of the PRKD gene family, and clinical behavior with frequent metastases at the time of presentation of the primary tumor. Early nodal metastatic disease is seen in most cases of CASG; yet, they are still associated with indolent clinical behavior, making it a unique neoplasm among all low-grade salivary gland tumors. SPA is a rare sclerosing tumor of the salivary glands characterized by the combination of cystic ductal structures with variable cell lining including vacuolated, apocrine, mucinous, squamous, and foamy cells, by prominent large acinar cells with coarse eosinophilic cytoplasmic zymogen-like granules, and by closely packed ductal structures, surrounded by a peripheral myoepithelial layer and stromal fibrosis with focal inflammatory infiltrates. SPA frequently harbors intraductal epithelial dysplastic proliferations ranging from mild dysplasia to severe dysplasia/carcinoma in situ. Moreover, SPA has been proven to be a clonal process by HUMARA assay and is associated with considerable risk of recurrence. Therefore, on the basis of all these newly recognized findings, we believe that SPA is likely a neoplasm, and we suggest the name "sclerosing polycystic adenoma." The mucinous variant of myoepithelioma is a myoepithelial tumor with foci of prominent cytoplasmic clearing frequently containing intracellular mucin material and having signet-ring morphology.

Entities:  

Mesh:

Year:  2017        PMID: 28614209     DOI: 10.1097/PAS.0000000000000883

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  MR imaging features of mammary analogue secretory carcinoma and acinic cell carcinoma of the salivary gland: a preliminary report.

Authors:  Nobuo Kashiwagi; Shin Ichi Nakatsuka; Takamichi Murakami; Eisuke Enoki; Kazuhiro Yamamoto; Katsuyuki Nakanishi; Takaaki Chikugo; Yoshitaka Kurisu; Masatomo Kimura; Tomoko Hyodo; Akio Tsukabe; Takahide Kakigi; Yasuhiko Tomita; Kazunari Ishii; Yoshifumi Narumi; Yukinobu Yagyu; Noriyuki Tomiyama
Journal:  Dentomaxillofac Radiol       Date:  2018-03-08       Impact factor: 2.419

2.  Polymorphous adenocarcinoma of salivary glands.

Authors:  Ximena Mimica; Nora Katabi; Marlena R McGill; Ashley Hay; Daniella Karassawa Zanoni; Jatin P Shah; Richard J Wong; Marc A Cohen; Snehal G Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2019-06-07       Impact factor: 5.337

3.  AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.

Authors:  Jan-Henrik Mikesch; Wolfgang Hartmann; Linus Angenendt; Otmar Huber; Christoph Schliemann; Maria Francisca Arteaga; Eva Wardelmann; Claudia Rudack; Wolfgang E Berdel; Markus Stenner; Inga Grünewald
Journal:  Cell Oncol (Dordr)       Date:  2018-06-05       Impact factor: 6.730

4.  Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Authors:  Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin
Journal:  Cancer Cytopathol       Date:  2020-04-08       Impact factor: 5.284

Review 5.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

6.  Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study.

Authors:  Bin Xu; Andrea L Barbieri; Justin A Bishop; Simon I Chiosea; Snjezana Dogan; Silvana Di Palma; William C Faquin; Ronald Ghossein; Martin Hyrcza; Vickie Y Jo; James S Lewis; John R Lozada; Michal Michal; Fresia G Pareja; Bayardo Perez-Ordonez; Manju L Prasad; Bibianna Purgina; Jorge S Reis-Filho; Theresa Scognamiglio; Ana P M Sebastiao; Raja R Seethala; Alena Skálová; Stephen M Smith; Merva S Tekkeşin; Lester D R Thompson; Jason K Wasseman; Bruce M Wenig; Ilan Weinreb; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2020-04       Impact factor: 6.298

7.  Sclerosing polycystic adenosis of lower lip: A new and rare salivary gland entity.

Authors:  Rudrayya Shivanand Puranik; Vg Bhagya Shree; Surekha R Puranik; Praveen S Anigol
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.